Sotera Health (SHC) Segment Income Breakdown

Reports operating profit for each business segment after direct costs, revealing which units generate the most profit and which are margin-challenged. Segment income shows how pricing, costs, and scale affect profitability, whether some units subsidize others, and where management can focus to improve returns or restructure. Consistent segment-level profit growth indicates stronger cash conversion to support investment and debt reduction.

Sterigenics is the primary earnings engine—consistent, margin‑expanding segment income that drove the beat and supports the raised guide—while Nordion is an increasingly meaningful but lumpy contributor tied to Cobalt‑60 harvest timing, so quarter-to-quarter volatility persists. Nelson Labs is recovering sequential margins toward the company's low‑to‑mid‑30s target but still shows year‑over‑year cost pressure. Management’s guidance raise and higher capex signal confidence in growth and capacity, but watch FX swings, shipment timing and rising depreciation/legal overhangs.